Home > News
News
- Oct. 21, 2024
- EPOC Researchers catalog has been update
- Jun. 21, 2024
- Division of Innovative Pathology and Laboratory Medicine(Kashiwa) Publications list has been updated
- Apr. 26, 2024
- Division of Innovative Pathology and Laboratory Medicine(Kashiwa) Member list has been updated
- Dec. 20, 2023
- Division of Innovative Pathology and Laboratory Medicine(Kashiwa) Publications list has been updated
- Nov. 29, 2023
- Molecular Mechanisms of Chromosomal Instability and Anti-Tumor Immune Activation Induced by DNA Replication Stress
- Jun. 23, 2023
- Division of Innovative Pathology and Laboratory Medicine(Kashiwa) Publications list has been updated
- May 9, 2023
- Division of Innovative Pathology and Laboratory Medicine(Kashiwa) Member List has been updated
- May 1, 2023
- Division of Cancer Immunotherapy (Kashiwa)Publications list has been updated
- Apr. 12, 2023
- Start of Clinical Research of the First Japanese-Produced Next-Generation Photon Counting Computed Tomography
- Apr. 3, 2023
- Division of Innovative Pathology and Laboratory Medicine(Kashiwa) Publications list has been updated
- Jan. 5, 2023
- Moonshot Research and Development Program ‘Actualization of a cancer-free society through regulation of chronic inflammation’ launched
- Nov. 18, 2022
- Researchers from National Cancer Center on ‘Highly Cited Researchers 2022’ List
- Sep. 27, 2022
- Teijin, J-TEC, Mitsui Fudosan and NCC to Establish Regenerative Medicine Platform
- Aug. 3, 2022
- Division of Innovative Pathology and Laboratory Medicine(Kashiwa) Publications list has been updated
- May 25, 2022
- Cooperation with the U.S. National Cancer Institute welcomed by Japan-US leaders in joint statement- role of National Cancer Center highlighted
- May 13, 2022
- Division of Innovative Pathology and Laboratory Medicine(Kashiwa) Member List has been updated
- Apr. 12, 2022
- Hiroyoshi Nishikawa honored with a prestigious Commendation from the Minister of Education, Culture, Sports, Science and Technology
- Mar. 25, 2022
- Franco-Japanese immuno-oncology webinar 2st session held
- Mar. 8, 2022
- Division of Innovative Pathology and Laboratory Medicine(Kashiwa) Publications list has been updated
- Feb. 1, 2022
- Division of Innovative Pathology and Laboratory Medicine(Kashiwa) Publications list has been updated
- Jan. 28, 2022
- Franco-Japanese immuno-oncology webinar 1st session held
- Jan. 4, 2022
- Division of Innovative Pathology and Laboratory Medicine(Kashiwa) English page has been updated
- Nov. 22, 2021
- Memorandum of Understanding signed with Frederick National Laboratory for Cancer Research
- Nov. 15, 2021
- Activated WNT/β-catenin pathway induces resistance to immunotherapies in cancers harboring high tumor mutation burden
- Nov. 12, 2021
- Study shows efficacy of dual-HER2 targeted therapy for patients with HER2-positive colorectal cancer
- Oct. 4, 2021
- EPOC Project has been update
- Sep. 1, 2021
- Division of Innovative Pathology and Laboratory Medicine(Kashiwa) Publications list has been updated
- Aug. 18, 2021
- Division of Developmental Therapeutics Members has been updated
- Aug. 2, 2021
- Division of Innovative Pathology and Laboratory Medicine(Kashiwa) Publications list has been updated
- Jul. 14, 2021
- Division of Translational Genomics(Kashiwa) Publications list has been updated
- Jul. 1, 2021
- Division of Innovative Pathology and Laboratory Medicine(Kashiwa) Publications list has been updated
- Jun. 1, 2021
- Division of Innovative Pathology and Laboratory Medicine(Kashiwa) Publications list has been updated
- May 18, 2021
- EPOC Project has been update
- May 14, 2021
- NATIONAL CANCER CENTER AND EISAI COMMENCE JOINT RESEARCH AND DEVELOPMENT PROJECT “BASIC RESEARCH ON THE DRUG DISCOVERY AND DEVELOPMENT TO ACCELERATE DEVELOPMENT OF ANTICANCER DRUGS IN TREATMENT OF PATIENTS WITH RARE CANCERS AND REFRACTORY CANCERS”, USING PDX WITH HIGH PREDICTABILITY OF CLINICAL OUTCOMES, AND CANCER GENOME DATA
- May 6, 2021
- Division of Innovative Pathology and Laboratory Medicine(Kashiwa) Publications list has been updated
- Apr. 1, 2021
- Division of Innovative Pathology and Laboratory Medicine(Kashiwa) Publications list has been updated
- Feb. 25, 2021
- Division of Innovative Pathology and Laboratory Medicine(Kashiwa) Publications list has been updated
- Feb. 2, 2021
- Deep Vision: Near-Infrared Imaging and Machine Learning Can Identify Hidden Tumors
- Feb. 1, 2021
- Division of Innovative Pathology and Laboratory Medicine(Kashiwa) Publications list has been updated
- Jan. 6, 2021
- Division of Innovative Pathology and Laboratory Medicine(Kashiwa) Publications list has been updated
- Dec. 1, 2020
- Division of Innovative Pathology and Laboratory Medicine(Kashiwa) English page has been updated
- Nov. 25, 2020
- Hiroyoshi Nishikawa Elected AAAS Fellow
- Nov. 17, 2020
- Hiroyoshi Nishikawa Honoured with the 2020 SITC ‘Team Science Award’
- Nov. 4, 2020
- EPOC researchers catalog for FY2020 has been posted
- Sep. 1, 2020
- A novel biomarker for predicting clinical efficacy of PD-1 blockade therapies
- Aug. 20, 2020
- NCC joins GSK’s oncology development network
- Feb. 28, 2020
- EPOC researchers catalog for FY2019 has been posted
- Feb. 17, 2020
- Dr. Yasuhiro Matsumura (Chief, Division of Developmental Therapeutics, EPOC) has published from Springer
- Jul. 10, 2019
- The research activity of Division of Functional Imaging,EPOC was highlighted at SNMMI 2019
- Jul. 8, 2019
- Amongst articles published in Cancer Science between January 2017 and December 2018, an article of Division of Cancer Immunnotherapy received some of the most downloads in the 12 months following online publication.
- May 23, 2019
- New Memorandum of Understanding signed with Cancer Center at Beth Israel Deaconess Medical Center
- Mar. 26, 2019
- Launch a joint research project on a new cancer immunotherapy using liposome, a drug delivery system technology
－Goal is to identify its actions on immune cells, and elucidate the mechanism by which survival periods are extended－ - Nov. 19, 2018
- Quickening the pace of new anti-cancer agents Attracting nanoparticles full of cancer drugs to the stroma of a tumour is proving key to new therapeutics.
- Mar. 9, 2018
- WHO Classification of Tumours Series appoints Dr Ochiai to Editorial Board
- Feb. 14, 2018
- A secondary RET mutation in the activation loop conferring
resistance to vandetanib through allosteric effects